6.4 Incretin Receptor Activation Normalizes Cell Respiration, Oxidative Phosphorylation, and Glycolysis in Neurons Using the Seahorse analysis tool, which can measure glucose turnover, oxygen consumption, and ATP production, it was found that GLP-1 can enhance glycolytic activity in astrocyte cell culture
Beyond the saturation point, additional CJC-1295 Ipamorelin dosage produces little additional IGF-1 elevation while increasing compound consumption and potential side effects

Triple Receptor Mechanism Retatrutide is the first molecule to simultaneously engage all three receptors implicated in energy balance and body weight regulation: GLP-1 receptor: Reduces appetite, slows gastric emptying, improves glycemic control the same pathway as semaglutide (Ozempic/Wegovy) GIP receptor: Enhances insulin secretion and may contribute to fat mobilization the same dual pathway as tirzepatide (Mounjaro/Zepbound) Glucagon receptor: Increases energy expenditure, promotes hepatic fat oxidation, and drives thermogenesis a pathway unique to retatrutide among obesity therapeutics Clinical Significance In the Phase 2 trial published in the New England Journal of Medicine (2023), participants receiving the highest dose of retatrutide achieved a mean body weight reduction of 24.2% at 48 weeks with some participants losing over 30% of their body weight
Some tests require fasting
10.1080/03602532.2017.1354014 58 XuZ.ChenZ.LanT.HanY.YangN.WangC.et al (2023)